GYRE
NASDAQ · Biotechnology
Gyre Therapeutics Inc
$4.56
-1.86 (-28.94%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+556.9% upside
Low Target
$20.05
Average Target
$29.92
High Target
$33.42
Current Price
$4.56
Current
$4.56
$4.56
Target
$29.92
$29.92
$20.05
$29.92 avg
$33.42
Scenario Analysis
Bear Case
$20.05
340.2%
Low target
Base Case
$29.92
+556.9%
Avg target
Bull Case
$33.42
+633.7%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$9.14
-50.2% from high
52-Week Low
$3.97
+14.7% from low
Target vs 52W High
$29.92
+227.4% vs high
Next Earnings Report
Nov 18, 2026
10d
until earnings
EPS Est: $-0.13
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |